GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 20.89
-0.91 (-4.17%)
At close: May 12, 2026
GemPharmatech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 159.76 | 142.64 | 109.82 | 158.91 | 164.67 | 124.93 |
Depreciation & Amortization | 88.21 | 88.21 | 83.74 | 53.73 | 39.07 | 28.81 |
Other Amortization | 11.81 | 11.81 | 13.17 | 8.55 | 7.93 | 5.83 |
Loss (Gain) From Sale of Assets | 0.04 | 0.04 | -0.01 | 0.02 | 0.1 | - |
Asset Writedown & Restructuring Costs | 19.08 | 19.08 | - | - | - | 14.08 |
Loss (Gain) From Sale of Investments | -8.75 | -8.75 | -10.35 | -14.24 | -9.44 | -11.43 |
Provision & Write-off of Bad Debts | - | - | 3.29 | 9.09 | 8.53 | 6.96 |
Other Operating Activities | 22.29 | 16.78 | 18.93 | 20.14 | 11.48 | 1.21 |
Change in Accounts Receivable | -56.61 | -56.61 | -91.33 | -87.52 | -81.09 | -73.31 |
Change in Inventory | -18.76 | -18.76 | -7.1 | 2.38 | -19.39 | -11.91 |
Change in Accounts Payable | 22.2 | 22.2 | -27.48 | -23.85 | -7.7 | 23.89 |
Change in Other Net Operating Assets | 7.82 | 7.82 | 2.98 | 4.66 | 0.67 | 3.07 |
Operating Cash Flow | 249.66 | 227.03 | 90.31 | 116.57 | 105.98 | 113.31 |
Operating Cash Flow Growth | 114.87% | 151.37% | -22.52% | 9.99% | -6.47% | -12.69% |
Capital Expenditures | -88.28 | -104.99 | -113.68 | -205.9 | -190.31 | -89.07 |
Sale of Property, Plant & Equipment | 0.14 | 0.16 | - | 0.11 | 0.11 | - |
Investment in Securities | -15.51 | -15.51 | 259.21 | 176.24 | -814.72 | -275.19 |
Other Investing Activities | -15.79 | -346.24 | 13.36 | 10.94 | 10.26 | 10.53 |
Investing Cash Flow | -119.44 | -466.58 | 158.89 | -18.61 | -994.66 | -353.73 |
Short-Term Debt Issued | - | - | 97.95 | 86 | 11.99 | - |
Long-Term Debt Issued | - | 298.49 | - | - | - | 25 |
Total Debt Issued | 208.25 | 298.49 | 97.95 | 86 | 11.99 | 25 |
Short-Term Debt Repaid | - | - | -86 | -21.99 | -25 | - |
Long-Term Debt Repaid | - | -199.21 | -8.11 | -6.42 | -2.08 | -10.71 |
Total Debt Repaid | -189.68 | -199.21 | -94.11 | -28.42 | -27.08 | -10.71 |
Net Debt Issued (Repaid) | 18.57 | 99.28 | 3.84 | 57.58 | -15.09 | 14.29 |
Issuance of Common Stock | 14.52 | 14.52 | - | - | 1,044 | - |
Repurchase of Common Stock | - | - | -32.67 | - | - | - |
Common Dividends Paid | -60.96 | -61.22 | -80.11 | -17.87 | -0.28 | -0.68 |
Other Financing Activities | -25.27 | -25.69 | - | -0.43 | -14.22 | -3.39 |
Financing Cash Flow | -53.14 | 26.89 | -108.94 | 39.29 | 1,014 | 10.23 |
Foreign Exchange Rate Adjustments | -7.5 | -2.61 | 0.96 | 1.15 | 2.63 | -0.46 |
Net Cash Flow | 69.58 | -215.27 | 141.22 | 138.4 | 128.08 | -230.65 |
Free Cash Flow | 161.38 | 122.04 | -23.36 | -89.33 | -84.33 | 24.24 |
Free Cash Flow Growth | 2058.07% | - | - | - | - | - |
Free Cash Flow Margin | 19.43% | 15.38% | -3.40% | -14.36% | -16.33% | 6.16% |
Free Cash Flow Per Share | 0.41 | 0.30 | -0.06 | -0.22 | -0.21 | 0.07 |
Cash Income Tax Paid | 29.28 | 29.28 | 40.59 | 3.44 | 3.17 | 27.32 |
Levered Free Cash Flow | 116.66 | 75.07 | -57.81 | -75.74 | -115.52 | -35.41 |
Unlevered Free Cash Flow | 117.04 | 75.07 | -55.12 | -74.01 | -115.21 | -34.95 |
Change in Working Capital | -42.77 | -42.77 | -128.27 | -119.63 | -116.35 | -57.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.